BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jørgensen JT. Companion and complementary diagnostics: an important treatment decision tool in precision medicine. Expert Review of Molecular Diagnostics 2020;20:557-9. [DOI: 10.1080/14737159.2020.1762573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cummings J, Kinney J. Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation. Medicina 2022;58:952. [DOI: 10.3390/medicina58070952] [Reference Citation Analysis]
2 Valla V, Alzabin S, Koukoura A, Lewis A, Nielsen AA, Vassiliadis E. Companion Diagnostics: State of the Art and New Regulations. Biomark Insights 2021;16:11772719211047763. [PMID: 34658618 DOI: 10.1177/11772719211047763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Jørgensen JT. An update on companion and complementary diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC. Expert Rev Mol Diagn 2021;21:445-54. [PMID: 33896308 DOI: 10.1080/14737159.2021.1920396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Poulsen TBG, Karamehmedovic A, Aboo C, Jørgensen MM, Yu X, Fang X, Blackburn JM, Nielsen CH, Kragstrup TW, Stensballe A. Protein array-based companion diagnostics in precision medicine. Expert Rev Mol Diagn 2020;20:1183-98. [PMID: 33315478 DOI: 10.1080/14737159.2020.1857734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]